alexa Preformulation Study Of Olopatadine Hydrochloride For The Treatment Ocular Allergy
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th International Conference on Nanotek & Expo
December 01-03, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Umay Merve Guven, Murat Sami Berkman and YaseminYazan
Posters: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.018
Ocular allergy or allergic diseases of the eye are one of the most frequently encountered disorders of the ocular surface. Among the ocular allergies allergic conjunctivitis is the most common type of allergy. It occurs seasonal or permanently, followed with the complaints of slight redness and swelling of the eyelids, itching, tearing, burning. Especially the treatment of allergic conjunctivitis is regular use of the drugs however what is important this type of therapy is the adjustment of dose. Conventional anti-allergic eye drops and various delivery systems can result in poor drug bioavailability due to the unique ocular anatomy and physiology. The novel approach in ocular treatment using controlled drug delivery system is to maintain prolonged residence time of the active material at the side of action. Olopatadine hydrochloride is an antiallergic agent with histamine H1 receptor antagonistic action used in ocular allergy and is classified as a second generation antihistamines. This generation causes fewer side effects than the other members. Therefore Olopatadine Hydrochloride was selected as an active material. In this study chitosan based nanaoparticle formulation studies were performed aiming enhanced corneal contact time with the help of mucoadeshive character of the natural polymer; Chitosan.
Umay Merve Guven got Bachelor?s degree in 2010/June from Anadolu University, Faculty of Pharmacy. She started her PhD programme in 2011/February. Since 2012 she has been working as a Research Assistant at the Department of Pharmaceutical Technology at Anadolu University.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version